CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7 | -22.2% | 586 | -12.8% | 0.01% | -28.6% |
Q2 2023 | $9 | -76.3% | 672 | -70.8% | 0.01% | -78.8% |
Q1 2023 | $38 | -53.7% | 2,303 | -47.6% | 0.03% | 0.0% |
Q4 2022 | $82 | -99.7% | 4,392 | +95.2% | 0.03% | +26.9% |
Q3 2022 | $29,000 | -9.4% | 2,250 | -50.3% | 0.03% | +4.0% |
Q2 2022 | $32,000 | -20.0% | 4,530 | -7.1% | 0.02% | -7.4% |
Q1 2022 | $40,000 | +900.0% | 4,878 | +768.0% | 0.03% | +350.0% |
Q4 2021 | $4,000 | – | 562 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
XML Financial, LLC | 40,000 | $119,000 | 0.04% |